Loading
NM
Nu-Med Plus, Inc. Stock: price and insider trades · United States
US·Mcap US$798.7k
Nu-Med Plus, Inc.: what insiders have been doing
Nu-Med Plus, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). 1 insider has disclosed 2 filings since 18 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
There has been no open-market purchase by an insider of Nu-Med Plus, Inc. for at least a year.
For context, the typical company on the same exchange (median of 5,808 companies) published 19 filings over the same period, against 2 filings here.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.01
Analyst consensus
Income statement
EBITDA-US$49k
Net income-US$56.2k0.0% margin
Valuation
Beta-2.11
Balance sheet & cash
Market capUS$798.7k
Total debtUS$212.5k
Free Cash Flow-US$48k
Profitability & ownership
ROA-329.5%
% insiders45.0%
% institutions0.0%
Last declaration on 25 August 2026
Declarations4 total
16,381,250 sharesCommon StockSEC:0001575872-26-000615:0
1,000,000 shares0Series X Super Voting Preferred StockSEC:0001575872-26-000615:1
200,000 shares@ US$0.019100.0% of flowCommon StockSEC:0001548123-23-000177:0
1,000,000 shares@ US$0.019100.0% of flowCommon StockSEC:0001548123-23-000176:0
4 of 4 declarations
About Nu-Med Plus, Inc.
Nu-Med Plus, Inc. is a company listed on the XNAS market. It specializes in developing innovative medical solutions.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
